|
1
|
Kershaw EE and Flier JS: Adipose tissue as
an endocrine organ. J Clin Endocrinol Metab. 89:2548–2556. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schäffler A, Müller-Ladner U, Schölmerich
J and Büchler C: Role of adipose tissue as an inflammatory organ in
human diseases. Endocr Rev. 27:449–467. 2006.PubMed/NCBI
|
|
3
|
Gnacińska M, Małgorzewicz S, Stojek M,
Łysiak-Szydłowska W and Sworczak K: Role of adipokines in
complications related to obesity: a review. Adv Med Sci.
54:150–157. 2009.PubMed/NCBI
|
|
4
|
Tilg H and Moschen AR: Adipocytokines:
mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–783. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siemińska L: Adipose tissue.
Pathophysiology, distribution, sex differences and the role in
inflammation and cancerogenesis. Endokrynol Pol. 58:330–342.
2007.(In Polish).
|
|
6
|
Gnacińska M, Małgorzewicz S,
Lysiak-Szydłowska W and Sworczak K: The serum profile of adipokines
in overweight patients with metabolic syndrome. Endokrynol Pol.
61:36–41. 2010.PubMed/NCBI
|
|
7
|
Flegal KM, Graubard BI, Williamson DF and
Gail MH: Cause-specific excess deaths associated with underweight,
overweight, and obesity. JAMA. 298:2028–2037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Falagas ME and Kompoti M: Obesity and
infection. Lancet Infect Dis. 6:438–446. 2006. View Article : Google Scholar
|
|
9
|
Dixit VD: Adipose-immune interactions
during obesity and caloric restriction: reciprocal mechanisms
regulating immunity and health span. J Leukoc Biol. 84:882–892.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hick RW, Gruver AL, Ventevogel MS, Haynes
BF and Sempowski GD: Leptin selectively augments thymopoiesis in
leptin deficiency and lipopolysaccharide-induced thymic atrophy. J
Immunol. 177:169–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Palmer G, Aurrand-Lions M, Contassot E, et
al: Indirect effects of leptin receptor deficiency on lymphocyte
populations and immune response in db/db mice. J Immunol.
177:2899–2907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Macia L, Delacre M, Abboud G, et al:
Impairment of dendritic cell functionality and steady-state number
in obese mice. J Immunol. 177:5997–6006. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farooqi IS, Matarese G, Lord GM, et al:
Beneficial effects of leptin on obesity, T cell hyporesponsiveness,
and neuroendocrine/metabolic dysfunction of human congenital leptin
deficiency. J Clin Invest. 110:1093–1103. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bresnahan MR and Newberne PM: Interaction
of diet and distemper virus infection on lipid metabolism in the
dog. Br J Exp Pathol. 49:223–234. 1968.PubMed/NCBI
|
|
15
|
Smith AG, Sheridan PA, Harp JB and Beck
MA: Diet induced obese mice have increased mortality and altered
immune responses when infected with influenza virus. J Nutr.
137:1236–1243. 2007.PubMed/NCBI
|
|
16
|
Gnacińska M, Małgorzewicz S, Guzek M,
Łysiał-Szydłowska W and Sworczak K: Adipose tissue activity in
relation to overweight or obesity. Endokrynol Pol. 61:160–168.
2010.PubMed/NCBI
|
|
17
|
Weisberg SP, McCann D, Desai M, Rosenbaum
M, Leibel RL and Ferrante AW Jr: Obesity is associated with
macrophage accumulation in adipose tissue. J Clin Invest.
112:1796–1808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fain JN, Madan AK, Hiler ML, Cheema P and
Bahouth SW: Comparison of the release of adipokines by adipose
tissue, adipose tissue matrix, and adipocytes from visceral and
subcutaneous abdominal adipose tissues of obese humans.
Endocrinology. 145:2273–2282. 2004. View Article : Google Scholar
|
|
19
|
Ceddia RB: Direct metabolic regulation in
skeletal muscle and fat tissue by leptin: implications for glucose
and fatty acids homeostasis. Int J Obes (Lond). 1175–1183. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fantuzzi G: Adipose tissue, adipokines,
and inflammation. J Allergy Clin Immunol. 115:911–919. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lutz CT and Quinn LS: Sarcopenia, obesity,
and natural killer cell immune senescence in aging: altered
cytokine levels as a common mechanism. Aging (Albany NY).
4:535–546. 2012.PubMed/NCBI
|
|
22
|
Bondue B, Wittamer V and Parmentier M:
Chemerin and its receptors in leukocyte trafficking, inflammation
and metabolism. Cytokine Growth Factor Rev. 22:331–338. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim JK: Fat uses a TOLL-road to connect
inflammation and diabetes. Cell Metab. 4:417–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ouchi N, Kihara S, Funahashi T, Matsuzawa
Y and Walsh K: Obesity, adiponectin and vascular inflammatory
disease. Curr Opin Lipidol. 14:561–566. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pöykkö SM, Kellokoski E, Hörkkö S, Kauma
H, Kesäniemi YA and Ukkola O: Low plasma ghrelin is associated with
insulin resistance, hypertension, and the prevalence of type 2
diabetes. Diabetes. 52:2546–2553. 2003.PubMed/NCBI
|
|
26
|
Witczak CA, Sharoff CG and Goodyear LJ:
AMP-activated protein kinase in skeletal muscle: from structure and
localization to its role as a master regulator of cellular
metabolism. Cell Mol Life Sci. 65:3737–3755. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andersson U, Filipsson K, Abbott CR, et
al: AMP-activated protein kinase plays a role in the control of
food intake. J Biol Chem. 279:12005–12008. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kola B, Hubina E, Tucci SA, et al:
Cannabinoids and ghrelin have both central and peripheral metabolic
and cardiac effects via AMP-activated protein kinase. J Biol Chem.
280:25196–25201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Towler MC and Hardie DC: AMP-activated
protein kinase in metabolic control and insulin signaling. Circ
Res. 100:328–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Minokoshi Y, Alquier T, Furukawa N, et al:
AMP-kinase regulates food intake by responding to hormonal and
nutrient signals in the hypothalamus. Nature. 428:569–574. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Steinberg GR, Michell BJ, van Denderen BJ,
et al: Tumor necrosis factor α-induced skeletal muscle insulin
resistance involves suppression of AMP-kinase signaling. Cell
Metab. 4:465–474. 2006.
|
|
32
|
Stark R, Ashley SE and Andrews ZB: AMPK
and the neuroendocrine regulation of appetite and energy
expenditure. Mol Cell Endocrinol. 366:215–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luquet S, Perez FA, Hnasko TS and Palmiter
RD: NPY/AgRP neurons are essential for feeding in adult mice but
can be ablated in neonates. Science. 310:683–685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gropp E, Shanabrough M, Borok E, et al:
Agouti-related peptide-expressing neurons are mandatory for
feeding. Nat Neurosci. 8:1289–1291. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hallows KR, Fitch AC, Richardson CA, et
al: Up-regulation of AMP-activated kinase by dysfunctional cystic
fibrosis transmembrane conductance regulator in cystic fibrosis
airway epithelial cells mitigates excessive inflammation. J Biol
Chem. 281:4231–4241. 2006. View Article : Google Scholar
|
|
36
|
Prasad R, Giri S, Nath N, Singh I and
Singh AK: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside
attenuates experimental autoimmune encephalomyelitis via modulation
of endothelial-monocyte interaction. J Neurosci Res. 84:614–625.
2006. View Article : Google Scholar
|
|
37
|
Hattori Y, Suzuki K, Hattori S and Kasai
K: Metformin inhibits cytokine-induced nuclear factor κB activation
via AMP-activated protein kinase activation in vascular endothelial
cells. Hypertension. 47:1183–1188. 2006.
|
|
38
|
Jakobsen SN, Hardie DG, Morrice N and
Tornqvist HE: 5′-AMP-activated protein kinase phosphorylates IRS-1
on Ser-789 in mouse C2C12 myotubes in response to
5-aminoimidazole-4-carboxamide riboside. J Biol Chem.
276:46912–46916. 2001.
|
|
39
|
Zheng D, MacLean PS, Pohnert SC, Knight
JB, Olson AL, Winder WW and Dohm GL: Regulation of muscle GLUT-4
transcription by AMP-activated protein kinase. J Appl Physiol
(1985). 91:1073–1083. 2001.PubMed/NCBI
|
|
40
|
Dixit VD, Schaffer EM, Pyle RS, et al:
Ghrelin inhibits leptin- and activation-induced proinflammatory
cytokine expression by human monocytes and T cells. J Clin Invest.
114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dann SG, Selvaraj A and Thomas G: mTOR
Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and
cancer. Trends Mol Med. 13:252–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cota D, Proulx K and Seeley RJ: The role
of CNS fuel sensing in energy and glucose regulation.
Gastroenterology. 132:2158–2168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ropelle ER, Pauli JR, Fernandes MF, et al:
A central role for neuronal AMP-activated protein kinase (AMPK) and
mammalian target of rapamycin (mTOR) in high-protein diet-induced
weight loss. Diabetes. 57:594–605. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim JH, Kim JE, Liu HY, Cao W and Chen JL:
Regulation of interleukin-6-induced hepatic insulin resistance by
mammalian target of rapamycin through the STAT3-SOCS3 pathway. J
Biol Chem. 283:708–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Harrison DE, Strong R, Sharp ZD, et al:
Rapamycin fed late in life extends lifespan in genetically
heterogeneous mice. Nature. 460:392–395. 2009.PubMed/NCBI
|
|
46
|
Nikolich-Zugich J and Messaoudi I: Mice
and flies and monkeys too: caloric restriction rejuvenates the
aging immune system of nonhuman primates. Exp Gerontol. 40:884–893.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Messaoudi I, Warner J, Fischer M, et al:
Delay of T cell senescence by caloric restriction in aged
long-lived nonhuman primates. Proc Natl Acad Sci USA.
103:19448–19453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang H, Youm YH, Nakata C and Dixit VD:
Chronic caloric restriction induces forestomach hypertrophy with
enhanced ghrelin levels during aging. Peptides. 28:1931–1936. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dixit VD, Yang H, Sun Y, Weeraratna AT,
Youm YH, Smith RG and Taub DD: Ghrelin promotes thymopoiesis during
aging. J Clin Invest. 117:2778–2790. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang H, Youm YH, Vandanmagsar B, et al:
Obesity increases the production of proinflammatory mediators from
adipose tissue T cells and compromises TCR repertoire diversity:
implications for systemic inflammation and insulin resistance. J
Immunol. 185:1836–1845. 2010. View Article : Google Scholar
|
|
51
|
Yamaguchi N, Argueta JG, Masuhiro Y, et
al: Adiponectin inhibits Toll-like receptor family-induced
signaling. FEBS Lett. 579:6821–6826. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Akira S, Takeda K and Kaisho T: Toll-like
receptors: critical proteins linking innate and acquired immunity.
Nat Immunol. 2:675–680. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
53
|
Shi H, Kokoeva MV, Inouye K, Tzameli I,
Yin H and Flier JS: TLR4 links innate immunity and fatty
acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
2006. View Article : Google Scholar : PubMed/NCBI
|
